Aurinia Pharmaceuticals Inc
NASDAQ:AUPH

Watchlist Manager
Aurinia Pharmaceuticals Inc Logo
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Watchlist
Price: 8.28 USD -1.19% Market Closed
Market Cap: 1.2B USD
Have any thoughts about
Aurinia Pharmaceuticals Inc?
Write Note

Aurinia Pharmaceuticals Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Aurinia Pharmaceuticals Inc
Cash from Financing Activities Peer Comparison

Comparables:
B
DRUG
TH
RPTX
COV
EDT

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Cash from Financing Activities
-$31.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
Bright Minds Biosciences Inc
CNSX:DRUG
Cash from Financing Activities
CA$2.2m
CAGR 3-Years
29%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Cash from Financing Activities
$20.3m
CAGR 3-Years
-20%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Repare Therapeutics Inc
NASDAQ:RPTX
Cash from Financing Activities
$842k
CAGR 3-Years
-85%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Covalon Technologies Ltd
XTSX:COV
Cash from Financing Activities
-CA$632.5k
CAGR 3-Years
9%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Spectral Medical Inc
TSX:EDT
Cash from Financing Activities
CA$13.7m
CAGR 3-Years
67%
CAGR 5-Years
207%
CAGR 10-Years
34%

See Also

What is Aurinia Pharmaceuticals Inc's Cash from Financing Activities?
Cash from Financing Activities
-31.2m USD

Based on the financial report for Jun 30, 2024, Aurinia Pharmaceuticals Inc's Cash from Financing Activities amounts to -31.2m USD.

Back to Top